Aurelia De Pauw

Aurelia De Pauw

Company: Tetra Bio-Pharma

Job title: Vice President, Clinical Programs & Medical Affairs


Aurelia De Pauw holds a master’s degree and Ph.D. in Science from the Gembloux Agro-Bio Tech, University of Liege and the University of Namur, Belgium. She has 13 years experience in preclinical and clinical research. Aurelia is the author of 10 peer-review articles in cellular metabolism and regenerative therapy. Her work in cardiac stem cell therapy was rewarded by the European Society of Cardiology, the Council on Basic Cardiovascular Science and the International Society for Heart Research. After establishing her career in basic sciences and regenerative therapy, she progressed from the laboratory bench tthe bedside where she gained an even deeper appreciation of the impact of research on patients and caregivers. Aurelia has extensive experience in numerous therapeutic categories including oncology, drug addiction, endocrinology, dermatology and cardiology, from phase I tphase IV clinical trialsShe’s now Vice-President of Clinical Programs and Medical Affairs at Tetra Bio-Pharma Inc., a pharmaceutical company developing cannabinoid-based drugs. 


Live Q&A 3:00 pm - 3:15 am

Read more

day: Day Two

Analyzing Clinical Data to Extract Insights into Clinical Endpoints and Mechanism of Action 2:20 pm

• Tetra Biopharma is currently pursuing a variety of clinical programs employing inhaled synthetic cannabinoid derived pharmaceuticals, including for pain and oncology indications • Analysis, interpretation and comparison of data across programs also connects these and is invaluable for the design of future studies and in decision making when it comes to future indications to…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.